|
V.V. Salukhov, B.V. Sagun
Key aspects of cardiovascular damage in COVID-19
|
№9/10 / 2023
|
|
E.I. Bugaeva, K.V. Zhmerenetsky, S.V. Dyachenko
On certain problems of diagnosis, treatment and prospects for the rehabilitation of patients with circulatory diseases after coronavirus infection COVID-19 (literature review)
|
№9/10 / 2023
|
|
O.A. Bashkina, I.V. Vyazovaya, D.F. Sergienko
Pediatric inflammatory multisystem syndrome associated with COVID-19: a clinical case
|
№9 / 2022
|
|
I.S. Burashnikova
The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19
|
№8 / 2021
|
|
I.S. Burashnikova
The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19
|
№8 / 2021
|
|
N.O. Yuldasheva, R.I. Kunafina, D.D. Sakaeva, D.E. Baykov, R.R. Suleymanova
Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University
|
№11 / 2020
|
Русский
